Spinal Cord Pilomyxoid Astrocytoma: An Unusual Tumor

2007 ◽  
Vol 17 (4) ◽  
pp. 371-374 ◽  
Author(s):  
Mishal Mendiratta-Lala ◽  
Shehanaz Kader Ellika ◽  
Jorge A. Gutierrez ◽  
Suresh C. Patel ◽  
Rajan Jain

Pilomyxoid astrocytoma (PMA) is an atypical subtype of pilocytic astrocytoma (PA), which presents in children and young adults. The incidence of PMA is low, so there is no standardized treatment protocol for it. Here, we present a 62-year-old woman with recurrent PMA, which is important for the understanding and treatment of the disease.


2010 ◽  
Vol 27 (2) ◽  
pp. 313-321 ◽  
Author(s):  
Dimitrios Paraskevopoulos ◽  
Ioannis Patsalas ◽  
Georgios Karkavelas ◽  
Nikolaos Foroglou ◽  
Ioannis Magras ◽  
...  

Neurosurgery ◽  
2005 ◽  
Vol 56 (1) ◽  
pp. E206-E210 ◽  
Author(s):  
Ricardo J. Komotar ◽  
Benjamin S. Carson ◽  
Chandrankant Rao ◽  
Sara Chaffee ◽  
Patricia T. Goldthwaite ◽  
...  

Abstract OBJECTIVE AND IMPORTANCE: Pilomyxoid astrocytoma (PMA) is a recently described, rare, circumscribed glioma similar to pilocytic astrocytoma. Despite its circumscribed nature, PMA implies a worse overall outcome than typical pilocytic astrocytoma. All PMAs reported to date involved the hypothalamic/chiasmatic region. Since these original reports, we have encountered three tumors in the spinal cord with histological features identical to those of PMA. CLINICAL PRESENTATION: We report three male pediatric patients. The first patient presented at age 6 with back pain and constipation. The second patient presented at age 8 with back pain and a bout of urinary incontinence. The third patient, a neonate, presented with respiratory failure and hypotonia. INTERVENTION: The first patient's cervical and thoracic neoplasm was treated with subtotal resection and multiple laminectomies and spinal fusion for recurrence. The second patient underwent gross total resection of his thoracic neoplasm. The neonate underwent laminectomy and biopsy of his holocord tumor. CONCLUSION: PMAs typically occur in the hypothalamic region and within the first 4 years of life. Tumors with identical histological features are being recognized outside this typical clinical setting. The cases presented in this report suggest that PMA can occur at a later age and can involve the spinal cord. We believe that increased recognition of these circumscribed gliomas will help to elucidate their nature and lead to better management decisions.


2020 ◽  
Vol 22 (Supplement_3) ◽  
pp. iii369-iii369
Author(s):  
Anna Avagyan ◽  
Lilit Sargsyan ◽  
Julia Hoveyan ◽  
Samvel Iskanyan ◽  
Samvel Bardakhchyan ◽  
...  

Abstract BACKGROUND Pilomyxoid astrocytoma (PMA) is a glial tumor that occurs predominantly in the hypothalamic-chiasmatic region and rarely in spinal cord. It has similar features as pilocytic astrocytomas, with some distinct histological characteristics and worse prognosis. The 2007 WHO recognized PMA as a Grade II glioma due to its aggressive behavior and dissemination tendency, but according to 2016 version grading of the pilomyxoid variant is under research. Here we report a case with a rare location, aggressive behavior and rapid progression. CASE PRESENTATION: A 7-year-old boy presented with headache, nausea, vomiting. Imaging revealed an intramedullary tumor extending from C2 to C6 with hydrocephalus. A ventriculo-peritoneal shunt and complete surgical resection were performed with significant improvement in the patient’s condition. Histopathological findings were consistent with pilomyxoid variant of pilocytic astrocytoma, with negative BRAF V600E and MGMT. Three months later, the follow-up imaging revealed disease recurrence with leptomeningeal metastases, for which the patient received standard-dose craniospinal irradiation 35.2 Gy with boosts to tumor bed and metastatic sites 49.6 Gy and 54 Gy respectively. 11 months later tumor progression was revealed with new metastatic lesions in the bones. Patient received 6 cycles of chemotherapy with TMZ and Avastin, but continued to suffer disease progression on therapy and he succumbed to his disease at 24 months from diagnosis. CONCLUSION Given the rarity of documented patients with spinal pilomyxoid astrocytoma with rapid progression, as well as the lack of certain WHO classification and treatment guidelines, this case report might be useful for development of more efficient treatment strategies.


2013 ◽  
Vol 61 (6) ◽  
pp. 677 ◽  
Author(s):  
Yulun Xu ◽  
Liang Wu ◽  
Tao Yang ◽  
Chenlong Yang

2021 ◽  
Vol 9 (7) ◽  
Author(s):  
Mohamed A. Almzeogi ◽  
Zeyad A. Abousabie ◽  
Jelena Kostic ◽  
Aleksandar M. Janicijevic ◽  
Goran Tasic

2008 ◽  
Vol 150 (7) ◽  
pp. 729-731 ◽  
Author(s):  
A. Sajadi ◽  
R.-C. Janzer ◽  
T.-L. C. Lu ◽  
J. M. Duff

2016 ◽  
Vol 9 (3) ◽  
pp. 568-573 ◽  
Author(s):  
Anastasie M. Dunn-Pirio ◽  
Elizabeth Howell ◽  
Roger E. McLendon ◽  
Katherine B. Peters

Introduction: Pilomyxoid astrocytoma (PMA) is a rare and more aggressive variant of pilocytic astrocytoma, which usually affects young children and is most often located in the hypothalamic/chiasmatic region. The association of PMA with underlying genetic disorders is not well known. Methods: We identified a 23-year-old woman with a PMA of the spinal cord who was simultaneously diagnosed with neurofibromatosis type 1. Diagnosis of neurofibromatosis type 1 was made clinically and confirmed with genetic testing that revealed a heterozygous one-amino-acid deletion (c.2970–2972 delAAT) in exon 17 of the NF1 gene, which is correlated with a milder phenotype. The patient underwent a partial surgical resection of the spinal cord tumor followed by adjuvant carboplatin 560 mg/m2 every 4 weeks. Radiation was avoided due to risks associated with neurofibromatosis type 1. Results: At the 11-month follow-up, the patient maintained a partial radiographic response as well as complete resolution of her neurologic deficits. Conclusion: To our knowledge, this is the first reported case of an adult patient with neurofibromatosis type 1 and a spinal cord PMA. Single-agent carboplatin was effective and well-tolerated.


Sign in / Sign up

Export Citation Format

Share Document